Infection by Enteroinvasive Escherichia coli: Complete ICD-11 Coding Guide

1. Introduction

Infection by enteroinvasive Escherichia coli (EIEC) represents a specific form of bacterial intestinal disease that deserves special attention in contemporary clinical practice. Unlike other pathogenic strains of E. coli, EIEC possess the unique capacity to directly invade the epithelial cells of the intestine, sharing virulence mechanisms with the genus Shigella, which results in clinical manifestations characteristic of bacillary dysentery.

This condition presents significant clinical importance due to its capacity to cause episodes of bloody diarrhea with mucus, symptoms that can generate concern for both patients and healthcare professionals. Although it generally presents with milder manifestations than classic shigellosis, EIEC can cause outbreaks in environments with inadequate sanitary conditions, particularly affecting vulnerable populations such as young children and elderly individuals.

From an epidemiological perspective, infection by EIEC is considered less common than other forms of pathogenic E. coli, but its true prevalence may be underestimated due to diagnostic difficulties and frequent confusion with Shigella infections. Transmission occurs mainly through the fecal-oral route, via contaminated water or food, becoming a relevant public health problem in regions with deficient basic sanitation.

Correct coding of this condition using the ICD-11 system is critical for multiple purposes: it enables precise epidemiological tracking, facilitates sanitary surveillance studies, aids in public health resource planning, and ensures adequate documentation for administrative and reimbursement purposes. Clear distinction between EIEC and other forms of pathogenic E. coli is fundamental to guide appropriate therapeutic decisions and infection control measures.

2. Correct ICD-11 Code

Code: [1A03.2](/en/code/1A03.2)

Description: Infection by enteroinvasive Escherichia coli

Parent category: 1A03 - Intestinal infections by Escherichia coli

Official definition: Infection by Escherichia coli caused by strains of enteroinvasive E. coli (EIEC) that share virulence determinants with Shigella spp. EIEC organisms invade the epithelial cells of the intestine, resulting in a mild form of dysentery, often confused with dysentery caused by Shigella species. The disease is characterized by the appearance of blood and mucus in the stool of infected individuals.

This specific code was developed to accurately capture infections caused by this particular pathotype of E. coli, clearly distinguishing it from other categories such as EPEC (enteropathogenic), ETEC (enterotoxigenic), and EHEC (enterohemorrhagic). The ICD-11 classification recognizes the importance of differentiating these variants due to their distinct clinical manifestations, pathogenic mechanisms, and implications for clinical management.

The hierarchical structure of the code reflects its position within the broader spectrum of intestinal infections by E. coli, facilitating navigation and understanding of the relationships between different pathotypes. This systematic organization allows healthcare professionals and medical coders to quickly identify the appropriate code based on the specific clinical and laboratory characteristics of the case.

3. When to Use This Code

The code 1A03.2 should be applied in specific clinical situations where there is confirmation or strong evidence of EIEC infection. Below are detailed practical scenarios:

Scenario 1: Dysentery Confirmed by Culture A patient presents with an acute episode of diarrhea containing visible blood and mucus for 48 hours, accompanied by intense abdominal cramping and tenesmus. Stool culture identifies E. coli with invasive characteristics confirmed by molecular or serological tests specific for EIEC. In this case, code 1A03.2 is fully justified by laboratory confirmation of the specific pathogen.

Scenario 2: Documented Epidemiological Outbreak During investigation of an outbreak in an institution, multiple individuals develop symptoms compatible with dysentery after consumption of a common food item. Microbiological analysis of the food and patient samples confirms EIEC as the etiological agent. All confirmed or probable cases within this outbreak should receive code 1A03.2, even those without individual confirmation, when there is strong epidemiological linkage.

Scenario 3: Characteristic Clinical Presentation with Microscopic Examination Patient with bloody diarrhea and presence of abundant fecal leukocytes on microscopic examination, with E. coli isolation on culture, even without immediate molecular typing. When the clinical-epidemiological context strongly suggests EIEC (for example, pattern of mild to moderate dysentery, without EHEC characteristics), and other pathogens have been excluded, the code may be applied based on typical clinical presentation.

Scenario 4: Traveler with Post-Exposure Dysentery Individual who developed dysentery after travel to a region with poor sanitation, presenting with bloody and mucoid stools, low-grade fever, and symptoms that resolve within a few days. When laboratory investigation identifies E. coli with an invasive profile, code 1A03.2 appropriately documents this acquired infection.

Scenario 5: Child with Mild Dysentery School-age child presents with episodes of stools containing streaks of blood and mucus, cramping abdominal pain, and low-grade fever. Stool culture reveals E. coli and subsequent tests confirm EIEC strains. This pattern of relatively mild dysentery in a child is characteristic of EIEC and justifies the use of code 1A03.2.

Scenario 6: Retrospective Confirmation by Molecular Biology Patient treated empirically for bacterial dysentery has later confirmation by PCR or genetic sequencing of EIEC in an archived sample. Retrospective coding with 1A03.2 is appropriate to update medical records and contribute to accurate epidemiological data.

4. When NOT to Use This Code

It is fundamental to recognize situations where code 1A03.2 is not appropriate, avoiding coding errors that may compromise medical records and epidemiological data:

Diarrhea without Invasive Characteristics When the patient presents with profuse watery diarrhea without blood or visible mucus, even if E. coli is isolated, code 1A03.2 should not be used. These presentations suggest other pathotypes such as ETEC or EPEC, which have specific codes.

Confirmed Shigella Infection Although EIEC and Shigella share pathogenic mechanisms and similar clinical manifestations, when culture definitively identifies Shigella spp., the appropriate code belongs to the shigellosis category (1A03.Y or specific codes for Shigella), not 1A03.2. The microbiological distinction should prevail over clinical similarity.

Hemolytic-Uremic Syndrome or Severe Hemorrhagic Colitis Patients with profuse bloody diarrhea, absence of fever, and development of complications such as hemolytic-uremic syndrome strongly suggest EHEC (enterohemorrhagic E. coli), especially Shiga toxin-producing strains. In these cases, the correct code is 1A03.3, not 1A03.2.

Traveler's Diarrhea Without Invasive Component Typical presentations of traveler's diarrhea, characterized by frequent watery stools without blood, even in the context of international travel, are generally not caused by EIEC. ETEC is the most common agent in these situations, justifying code 1A03.1.

Viral or Parasitic Gastroenteritis When investigation reveals viral agents (rotavirus, norovirus) or parasitic agents (Giardia, Entamoeba) as the cause of diarrhea, specific codes for these conditions should be used, even if there is incidental co-isolation of non-pathogenic E. coli.

5. Step-by-Step Coding Process

Step 1: Assess Diagnostic Criteria

The diagnosis of EIEC infection requires systematic evaluation of clinical and laboratory criteria. Clinically, seek the characteristic triad: diarrhea with visible blood, presence of mucus in stool, and symptoms of colitis (abdominal cramps, tenesmus). Fever is usually present but tends to be low to moderate.

Laboratory confirmation is essential and can be obtained through multiple approaches. Stool culture with isolation of E. coli is the first step, followed by specific tests to identify the invasive pathotype. Methods include cell invasion assays, detection of virulence genes by PCR (such as ipaH), or serotyping to identify known EIEC serotypes.

Microscopic examination of stool may reveal abundant leukocytes and erythrocytes, indicating intestinal inflammatory process. The presence of fecal leukocytes is a useful marker of invasive diarrhea, although it is not specific to EIEC.

Step 2: Verify Specifiers

Assess the severity of the clinical presentation, classifying it as mild, moderate, or severe based on frequency of bowel movements, degree of dehydration, intensity of systemic symptoms, and presence of complications. Most cases of EIEC present with mild to moderate severity.

Determine the duration of symptoms, differentiating acute presentations (less than 14 days) from persistent ones. EIEC typically causes acute self-limited disease lasting 5 to 7 days.

Document specific characteristics such as presence of fever, degree of dehydration, need for hospitalization, and response to treatment. This information, although it does not change the main code 1A03.2, is important for complete clinical documentation.

Step 3: Differentiate from Other Codes

1A03.0: Infection by enteropathogenic Escherichia coli (EPEC) The key difference lies in the pathogenic mechanism and clinical presentation. EPEC causes watery diarrhea without an invasive component, through adhesion and attaching and effacing lesions of intestinal microvilli. There is no blood or mucus in stool, and fecal leukocytes are rare. EPEC is more common in infants, whereas EIEC affects all age groups.

1A03.1: Infection by enterotoxigenic Escherichia coli (ETEC) ETEC produces enterotoxins that cause profuse secretory watery diarrhea, similar to cholera in severe cases. The fundamental difference is the absence of invasion of the intestinal mucosa, resulting in watery stool without blood, mucus, or leukocytes. ETEC is the most common cause of traveler's diarrhea, whereas EIEC causes dysentery.

1A03.3: Infection by enterohemorrhagic Escherichia coli (EHEC) EHEC, including the O157:H7 strain, produces Shiga toxins that cause severe hemorrhagic colitis. The critical difference lies in the absence of fever (or low-grade fever) in EHEC versus fever present in EIEC, greater severity of bloody diarrhea in EHEC, and risk of serious complications such as hemolytic-uremic syndrome exclusive to EHEC. Fecal leukocytes are less prominent in EHEC.

Step 4: Required Documentation

Checklist of mandatory information for appropriate coding:

✓ Detailed description of stool characteristics (presence of blood, mucus, consistency)
✓ Associated symptoms (fever, abdominal cramps, tenesmus, nausea)
✓ Duration of symptoms and temporal evolution
✓ Stool culture results with E. coli identification
✓ Confirmatory tests for EIEC pathotype (PCR, serotyping, invasion assays)
✓ Microscopic examination of stool (leukocytes, erythrocytes)
✓ Epidemiological context (outbreaks, travel, exposures)
✓ Exclusion of other enteric pathogens
✓ Assessment of severity and need for interventions
✓ Response to implemented treatment

Record all findings in a chronological and structured manner, facilitating subsequent review and coding audit. The documentation should allow any healthcare professional to clearly understand why code 1A03.2 was selected.

6. Complete Practical Example

Clinical Case

A 28-year-old patient, previously healthy, seeks medical care with a complaint of diarrhea for 3 days. He reports that symptoms began abruptly with intense abdominal cramping and fever of 38.2°C. In the first 24 hours, he presented with frequent watery bowel movements (8-10 times), but on the second day he noticed the appearance of blood and mucus in the stool. He reports a sensation of incomplete evacuation (tenesmus) and worsening of cramping before bowel movements.

In the epidemiological history, the patient mentions having attended a social event 48 hours before symptom onset, where he consumed food prepared under questionable hygiene conditions. Other event participants also developed similar gastrointestinal symptoms.

On physical examination, the patient appears in fair general condition, mildly to moderately dehydrated, febrile (axillary temperature 38.0°C), with diffusely tender abdomen on palpation, especially in lower quadrants, without signs of peritoneal irritation. Increased bowel sounds.

Complementary tests were requested: complete blood count revealing leukocytosis with left shift (15,000 leukocytes/mm³, 12% bands); parasitological stool examination negative; stool culture collected before initiation of antibiotic therapy. Microscopic examination of stool demonstrated abundant presence of leukocytes and erythrocytes.

After 48 hours, the laboratory reports growth of E. coli in stool culture. Subsequent molecular tests (PCR) identify virulence genes characteristic of enteroinvasive E. coli (ipaH gene positive), confirming the diagnosis of EIEC infection.

The patient was initially treated with vigorous oral rehydration and symptomatic measures. Due to persistence of symptoms and bacterial confirmation, antibiotic therapy with fluoroquinolone was initiated for 3 days, with significant improvement of the condition. He was discharged with guidance on hygiene and transmission prevention.

Step-by-Step Coding

Criteria Analysis:

Clinical criteria present:
- Diarrhea with blood and mucus (defining characteristic)
- Fever (38.0-38.2°C)
- Intense abdominal cramping
- Tenesmus (sensation of incomplete evacuation)
- Acute onset of symptoms
Laboratory criteria present:
- Abundant fecal leukocytes (indicative of invasive process)
- Erythrocytes in stool
- Positive culture for E. coli
- Molecular confirmation of EIEC (ipaH gene positive)
- Leukocytosis with left shift on complete blood count
Epidemiological criteria:
- Exposure to potentially contaminated food
- Other cases with similar symptoms (outbreak)
- Compatible incubation period (48 hours)

Code Selected: 1A03.2 - Infection by enteroinvasive Escherichia coli

Complete Justification:

Code 1A03.2 is the most appropriate for this case based on multiple converging evidence. The clinical presentation of dysentery with blood and mucus in stool, accompanied by fever and symptoms of colitis, is highly characteristic of EIEC infection. Laboratory confirmation through culture with isolation of E. coli, followed by molecular identification of the invasive pathotype (ipaH gene), provides definitive diagnostic certainty.

Differentiation from other E. coli pathotypes is clear: the presence of blood and mucus excludes EPEC and ETEC; the fever present and moderate severity differ from the typical pattern of EHEC, which usually presents without fever and with greater severity. The absence of complications such as hemolytic-uremic syndrome also rules out EHEC.

The epidemiological context of a food-related outbreak reinforces the diagnosis, with EIEC being a recognized pathogen in foodborne outbreaks. The clinical course with improvement after antibiotic therapy is consistent with invasive bacterial infection.

Complementary Codes:

Code for dehydration (if applicable, depending on severity)
Code for fever (if documented separately for specific purposes)
Code for place of acquisition (foodborne outbreak), if the system allows additional specification

Complete documentation of this case allows adequate epidemiological tracking, contributes to outbreak surveillance, and justifies the therapeutic interventions performed.

7. Related Codes and Differentiation

Within the Same Category

1A03.0: Infection by enteropathogenic Escherichia coli (EPEC)

When to use 1A03.0: This code should be applied when E. coli infection causes watery diarrhea without an invasive component, particularly in infants and young children. EPEC is characterized by persistent diarrhea with watery stools, without blood or mucus.

When to use 1A03.2: Use this code when there is evidence of intestinal mucosa invasion, manifested by blood and mucus in stools, abundant fecal leukocytes, and symptoms of colitis.

Main difference: The pathogenic mechanism fundamentally distinguishes these entities. EPEC adheres to the intestinal mucosa causing microvillus injury without cellular invasion, resulting in secretory diarrhea. EIEC actively invades intestinal epithelial cells, causing cellular destruction and inflammation, manifesting as dysentery. The presence of blood and mucus in stools is the most reliable clinical marker to differentiate EIEC from EPEC.

1A03.1: Infection by enterotoxigenic Escherichia coli (ETEC)

When to use 1A03.1: Apply this code in cases of profuse watery diarrhea, secretory type, frequently associated with international travel ("traveler's diarrhea"). ETEC produces enterotoxins that cause intestinal hypersecretion without mucosa injury.

When to use 1A03.2: Select this code when the clinical presentation includes an inflammatory component with blood and mucus, indicating invasion of the intestinal mucosa.

Main difference: ETEC causes purely secretory diarrhea through toxins (heat-labile and heat-stable toxins) without cellular invasion, resulting in abundant watery stools without blood, similar to cholera in severe cases. EIEC causes invasive diarrhea with mucosa destruction, resulting in stools with blood and mucus. The absence of fecal leukocytes in ETEC versus abundant presence in EIEC is an important laboratory differentiator.

1A03.3: Infection by Shiga toxin-producing Escherichia coli (STEC)

When to use 1A03.3: This code is appropriate for infections by E. coli producing Shiga toxin (such as O157:H7), characterized by severe hemorrhagic colitis, absence of fever or low-grade fever, and risk of hemolytic-uremic syndrome.

When to use 1A03.2: Use this code when there is dysentery with fever present, mild to moderate severity, without risk of hemolytic-uremic syndrome, and confirmation of invasive strain without Shiga toxin production.

Main difference: STEC produces Shiga toxins that cause vascular damage in addition to intestinal injury, leading to severe hemorrhagic colitis and potentially hemolytic-uremic syndrome. The absence of fever is characteristic of STEC, whereas fever is common in EIEC. STEC causes more profuse and severe bloody diarrhea, with fewer fecal leukocytes compared to EIEC. Detection of Shiga toxin or stx genes by laboratory tests confirms STEC and excludes EIEC.

Differential Diagnoses

Shigellosis: The distinction between EIEC and Shigella is particularly challenging due to genetic and clinical similarity. Both cause dysentery with fever, blood, and mucus in stools. Differentiation requires definitive microbiological identification, as they share virulence plasmids. When Shigella is identified on culture, specific codes for shigellosis should be used.

Campylobacter colitis: Also causes bloody diarrhea with fever, but culture identifies Campylobacter jejuni. The clinical presentation may be indistinguishable, requiring laboratory confirmation.

Intestinal amebiasis: Entamoeba histolytica can cause dysentery, but generally with a more insidious course, less prominent fever, and identification of trophozoites or cysts on parasitological stool examination.

Ulcerative colitis or Crohn's disease: Chronic inflammatory bowel conditions may present with blood in stools, but the course is chronic or recurrent, not acute as in EIEC, and bacterial cultures are negative.

8. Differences with ICD-10

Equivalent ICD-10 code: A04.2 - Infection due to enteroinvasive Escherichia coli

Main changes in ICD-11:

The transition from ICD-10 to ICD-11 brought significant refinements in the coding of E. coli infections. In ICD-10, code A04.2 was used for EIEC, within the broader category A04 (Other bacterial intestinal infections). ICD-11 reorganized this structure, creating the specific category 1A03 dedicated exclusively to intestinal infections caused by E. coli, with subcategories for each pathotype.

The most notable change is the clearer and more logical hierarchical structure in ICD-11. Code 1A03.2 is explicitly positioned within 1A03 (Intestinal infections due to Escherichia coli), facilitating navigation and understanding of the relationships between different pathotypes. This organization better reflects contemporary microbiological knowledge about the various pathogenic mechanisms of E. coli.

ICD-11 also offers greater specificity in the definition, explicitly including the mention that EIEC shares virulence determinants with Shigella, important microbiological information that was not clearly expressed in ICD-10. This clarification helps coders better understand the nature of the condition.

Practical impact of these changes:

For healthcare professionals and coders, the transition requires familiarity with the new numerical structure (1A03.2 versus A04.2). Electronic medical record systems need to be updated to properly map old codes to new ones, maintaining continuity of epidemiological data.

The greater specificity of ICD-11 facilitates more precise epidemiological studies, allowing better tracking of different E. coli pathotypes. This is particularly relevant for outbreak surveillance and monitoring of antimicrobial resistance, which can vary among pathotypes.

For reimbursement and billing purposes in healthcare systems, the transition may require updating procedure tables and associated values. Clinical documentation should be sufficiently detailed to justify the specific code, especially during the transition period when auditors may be less familiar with the new coding.

9. Frequently Asked Questions

1. How is EIEC infection diagnosed?

EIEC diagnosis requires a combination of clinical evaluation and laboratory confirmation. Clinically, the presence of bloody diarrhea with mucus, fever, and symptoms of colitis (abdominal cramps, tenesmus) strongly suggests the diagnosis. Laboratory confirmation involves stool culture to isolate E. coli, followed by specific tests to identify the invasive pathotype. Methods include PCR to detect virulence genes (such as ipaH), cell invasion assays in cell culture, or serotyping to identify known EIEC serotypes. Microscopic examination of stool showing abundant leukocytes is a useful indicator of invasive process, although not specific to EIEC.

2. Is treatment for EIEC available in public health systems?

Yes, treatment for EIEC infection is widely available in public health systems. Most cases are self-limited and require only supportive measures, mainly adequate hydration, which can be achieved with oral rehydration solutions available free or at low cost. Antibiotics may be necessary in moderate to severe cases or in patients with risk factors, and medications such as fluoroquinolones, azithromycin, or sulfamethoxazole-trimethoprim are generally included in essential medicine lists. Access to microbiological diagnosis may vary between different health systems, but stool culture is a basic test available in most laboratories.

3. How long does treatment last?

Treatment duration varies according to severity and therapeutic approach. Mild cases without antibiotic therapy generally resolve spontaneously in 5 to 7 days with adequate supportive measures. When antibiotics are indicated, the typical course is 3 to 5 days, with 3 days often sufficient for uncomplicated cases. Hydration should be maintained throughout the symptomatic period and until normalization of bowel movements. Residual symptoms such as mild abdominal discomfort may persist for a few days after diarrhea resolution. It is important to complete the prescribed antibiotic course, even with early symptom improvement, to prevent relapse and reduce the risk of antimicrobial resistance development.

4. Can this code be used in medical certificates?

Yes, code 1A03.2 can and should be used in medical certificates when appropriate. Medical certificates frequently require diagnostic specification to justify absence from professional or school activities. EIEC infection is a legitimate condition that may require temporary absence, both for patient recovery and to prevent transmission to others. The typical absence period varies from 3 to 7 days, depending on symptom severity and type of professional activity. Professionals who handle food or work with vulnerable populations may require absence until confirmation of microbiological cure. Documentation should include the ICD-11 code and brief description of the condition, respecting medical confidentiality while providing sufficient information to justify the absence.

5. Can EIEC cause serious complications?

Although EIEC generally causes self-limited disease of mild to moderate severity, complications can occur, especially in vulnerable populations. Dehydration is the most common complication, particularly in young children, elderly individuals, and those with comorbidities. Severe dehydration can lead to electrolyte imbalances, acute kidney injury, and hypovolemic shock if not treated appropriately. Bacteremia is rare but possible, especially in immunocompromised patients. Reactive arthritis (Reiter syndrome) may develop weeks after intestinal infection in genetically predisposed individuals. Unlike EHEC, EIEC does not cause hemolytic-uremic syndrome. Toxic megacolon is an extremely rare but potentially fatal complication. Most complications can be prevented with adequate hydration and appropriate treatment.

6. How to prevent EIEC transmission?

EIEC prevention is based on hygiene and sanitation measures. Proper handwashing with soap and water, especially after using the bathroom and before handling food, is fundamental. Food should be prepared, stored, and cooked properly, with special attention to raw products and drinking water. In institutional settings or during outbreaks, contact isolation may be necessary to prevent transmission. Symptomatic patients should avoid preparing food for others and take extra care with personal hygiene. Healthcare professionals should follow standard and contact precautions when caring for infected patients. Improvements in basic sanitation and water treatment are essential public health measures to reduce EIEC incidence in communities.

7. Is there a difference in treatment between EIEC and other forms of pathogenic E. coli?

Yes, there are important differences in treatment between EIEC and other E. coli pathotypes. For EIEC, antibiotics may be beneficial in moderate to severe cases, reducing symptom duration and bacterial shedding. In contrast, antibiotics are generally contraindicated in EHEC (Shiga toxin-producing E. coli) infections due to increased risk of hemolytic-uremic syndrome. ETEC and EPEC often do not require antibiotic therapy, being treated mainly with hydration. Antimotility agents (such as loperamide) should be avoided in EIEC due to the invasive component, but may be used cautiously in ETEC. These differences underscore the importance of correct pathotype identification to guide appropriate therapeutic decisions.

8. When is hospitalization necessary in EIEC cases?

Hospitalization for EIEC infection is necessary in specific situations. Moderate to severe dehydration that does not respond to oral rehydration is the most common indication, requiring intravenous hydration. Patients with persistent vomiting that prevents adequate oral hydration may require admission. Vulnerable populations such as infants, elderly individuals, pregnant women, and immunocompromised patients with significant symptoms should be considered for hospitalization due to higher risk of complications. Warning signs include persistent high fever, severe abdominal pain, profuse intestinal bleeding, altered level of consciousness, or signs of sepsis. Most EIEC cases, however, can be managed on an outpatient basis with oral hydration, antibiotics when indicated, and appropriate clinical follow-up.

Conclusion

Precise coding of enteroinvasive Escherichia coli infection using ICD-11 code 1A03.2 is essential for adequate clinical documentation, effective epidemiological surveillance, and appropriate health resource management. Understanding the distinctive clinical characteristics of EIEC, particularly the presentation as dysentery with blood and mucus in stool resulting from intestinal mucosa invasion, allows clear differentiation from other E. coli pathotypes that require distinct codes.

Laboratory confirmation through culture with identification of the invasive pathotype provides diagnostic certainty, although the clinical-epidemiological context is often sufficient for appropriate coding in practical situations. Detailed documentation of clinical and laboratory findings not only justifies code selection but also contributes to broader epidemiological knowledge about this condition.

Healthcare professionals should be familiar with the nuances of ICD-11 coding for E. coli infections, recognizing that diagnostic specificity directly impacts therapeutic decisions, infection control measures, and clinical outcomes. The transition from ICD-10 to ICD-11 represents an opportunity to improve the accuracy of medical documentation and advance our collective understanding of intestinal infectious diseases.

External References

This article was prepared based on reliable scientific sources:

References verified on 2026-02-04

Infection by Enteroinvasive Escherichia coli

Partager